CSIMarket



Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Revenue Growth by Quarter and Year

Boston Scientific's Revenue results by quarter and year




BSX Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 3,127.00 2,708.00 5,398.00
III Quarter September - 2,932.00 2,659.00 2,707.00
II Quarter June - 3,077.00 2,003.00 2,631.00
I Quarter March 3,026.00 2,752.00 2,543.00 2,563.00
FY   3,026.00 11,888.00 9,913.00 13,299.00



BSX Revenue first quarter 2022 Y/Y Growth Comment
Boston Scientific Corporation achieved in the first quarter 2022, above Company average Revenue improvement of 9.96% year on year, to $ 3,026.00 millions.

Looking into first quarter 2022 results within Medical Equipment & Supplies industry 34 other companies have achieved higher Revenue growth. While Boston Scientific Corporation' s Revenue increase of 9.96% ranks overall at the positon no. 1258 in the first quarter 2022.




BSX Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 15.47 % -49.83 % 125.67 %
III Quarter September - 10.27 % -1.77 % 8.71 %
II Quarter June - 53.62 % -23.87 % 10.59 %
I Quarter March 9.96 % 8.22 % -0.78 % 6.39 %
FY   - 19.92 % -25.46 % 37.53 %

Financial Statements
Boston Scientific's first quarter 2022 Revenue $ 3,026.00 millions BSX's Income Statement
Boston Scientific's first quarter 2021 Revenue $ 2,752.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Revenue Growth >>


BSX Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 6.65 % 1.84 % 99.41 %
III Quarter September - -4.71 % 32.75 % 2.89 %
II Quarter June - 11.81 % -21.23 % 2.65 %
I Quarter March -3.23 % 1.62 % -52.89 % 7.15 %
FY (Year on Year)   - 19.92 % -25.46 % 37.53 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #35
Healthcare Sector #153
Overall #1258

Revenue Y/Y Growth Statistics
High Average Low
74.68 % 1.55 % -43.83 %
(Dec 31 2013)   (Sep. 30, 2015)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #35
Healthcare Sector #153
Overall #1258
Revenue Y/Y Growth Statistics
High Average Low
74.68 % 1.55 % -43.83 %
(Dec 31 2013)   (Sep. 30, 2015)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Boston Scientific's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
99.41 % 2.63 % -52.89 %
(Dec 31 2019)  


BSX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Boston Scientific Corporation realized fall in Revenue sequentially by -3.23% to $ 3,026.00 millions, from $ 3,127.00 millions declared in the previous reporting period.

Some cyclical influence have not recover the I. Quarter for the Boston Scientific Corporation, Álvaro Martín, a business contributor said and mentioned that average quarter on quarter Revenue growth is at 2.63% for the Medical Equipment & Supplies's company.

Within Medical Equipment & Supplies industry 66 other companies have achieved higher Revenue quarter on quarter growth. While Boston Scientific's Revenue growth quarter on quarter, overall rank is 1841.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #67
Healthcare Sector #286
Overall #1841
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #67
Healthcare Sector #286
Overall #1841
Revenue Q/Q Growth Statistics
High Average Low
99.41 % 2.63 % -52.89 %
(Dec 31 2019)  


BSX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Boston Scientific Corporation disclosed fall in Revenue sequentially by -3.23% to $ 3,026.00 millions, from $ 3,127.00 millions released in the previous reporting period.

Albeit seasonal factors commonly elevate I. Quarter 2022 performance, it clearly has not been substantial to salvage Boston Scientific's I. Quarter 2022 achievement, Álvaro Martín, a business contributor pointed out.

Within Medical Equipment & Supplies industry 66 other companies have achieved higher Revenue quarter on quarter growth. While Boston Scientific's Revenue growth quarter on quarter, overall rank is 1841.


Boston Scientific's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 12,162.00 $ 11,888.00 $ 11,469.00 $ 11,196.00 $ 10,122.00
Y / Y Revenue Growth (TTM) 20.15 % 19.92 % -9 % -11.5 % -23.77 %
Year on Year Revenue Growth Overall Ranking # 1236 # 671 # 3060 # 3070 # 1850
Seqeuential Revenue Change (TTM) 2.3 % 3.65 % 2.44 % 10.61 % 2.11 %
Seq. Revenue Growth (TTM) Overall Ranking # 1638 # 1928 # 2347 # 1150 # 2022




Cumulative Revenue growth Comment
Boston Scientific saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 20.15% year on year, to $ 12,162 millions if the fiscal year would have ended in Mar 31 2022.
Boston Scientific's trailing twelve months Revenue growth was higher than company's average 6.09% and higher than 19.92% growth in Dec 31 2021.
But sequential growth rate was less at 2.3 % from $11888 millions recorded in the period from Dec 31 2021 to Mar 31 2021 Álvaro Martín added on.
In spite of, it was evidence of positive momentum, while the usual Q/Q TTM Revenue advancement stands at 1.55%.
The momentum is even stronger from the previous reporting period clinched at 2.3 % increase from $11888 millions in twelve months ending a quarter before.

In the Healthcare sector 192 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 671 to 1236.

Revenue TTM Q/Q Growth Statistics
High Average Low
74.68 %
1.55 %
-43.83 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 57
Healthcare Sector # 193
Overall # 1236

Revenue TTM Y/Y Growth Statistics
High Average Low
71.7 %
6.09 %
-25.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 57
Sector # 256
S&P 500 # 1638
Cumulative Revenue growth Comment
Boston Scientific saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 20.15% year on year, to $ 12,162 millions if the fiscal year would have ended in Mar 31 2022.
Boston Scientific's trailing twelve months Revenue growth was higher than company's average 6.09% and higher than 19.92% growth in Dec 31 2021.
But from the previous reporting period rise was less at 2.3 % from $11888 millions recorded in twelve months ending a quarter Dec 31 2021 Álvaro Martín went on.
Still it was validation of convincing trend, as the usual sequential Revenue gain stands at 1.55%.
The progress was much more impressive from the previous reporting period showed at 2.3 % jump from $11888 millions in twelve months ending a quarter before.

In the Healthcare sector 192 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 671 to 1236.

Revenue TTM Q/Q Growth Statistics
High Average Low
74.68 %
1.55 %
-43.83 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 57
Healthcare Sector # 193
Overall # 1236

Revenue TTM Y/Y Growth Statistics
High Average Low
71.7 %
6.09 %
-25.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 57
Sector # 256
S&P 500 # 1638




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BSX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BSX's Competitors
Revenue Growth for Boston Scientific's Suppliers
Revenue Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Regeneron Pharmaceuticals Inc 17.26%$ 17.258 millions
U S Physical Therapy Inc17.21%$ 17.208 millions
Heron Therapeutics Inc 17.18%$ 17.180 millions
Insulet Corporation17.08%$ 17.083 millions
Amphastar Pharmaceuticals Inc 16.84%$ 16.839 millions
Cutera Inc 16.80%$ 16.804 millions
Pulmonx Corporation16.67%$ 16.670 millions
Supernus Pharmaceuticals inc 16.48%$ 16.477 millions
Surgery Partners Inc 16.35%$ 16.354 millions
Deciphera Pharmaceuticals Inc 16.17%$ 16.167 millions
Armata Pharmaceuticals Inc 15.95%$ 15.947 millions
Orasure Technologies Inc15.58%$ 15.576 millions
Electromed Inc 15.41%$ 15.409 millions
Neuronetics Inc 15.41%$ 15.405 millions
Intuitive Surgical Inc 15.14%$ 15.138 millions
Repro Med Systems Inc 14.98%$ 14.977 millions
Eli Lilly And Company14.76%$ 14.758 millions
Pacific Biosciences Of California Inc 14.40%$ 14.401 millions
Epizyme Inc 13.96%$ 13.956 millions
Psychemedics Corp13.92%$ 13.916 millions
Abbott Laboratories13.76%$ 13.762 millions
Ensign Group Inc13.74%$ 13.741 millions
Resmed Inc 13.66%$ 13.663 millions
Viemed Healthcare Inc 13.51%$ 13.510 millions
Innovage Holding Corp 13.47%$ 13.468 millions
Co diagnostics Inc 13.35%$ 13.355 millions
Liquidia Corporation13.24%$ 13.243 millions
Phibro Animal Health Corp13.17%$ 13.172 millions
Viveve Medical Inc 13.17%$ 13.172 millions
Regen Biopharma Inc12.84%$ 12.835 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PTC's Profile

Stock Price

PTC's Financials

Business Description

Fundamentals

Charts & Quotes

PTC's News

Suppliers

PTC's Competitors

Customers & Markets

Economic Indicators

PTC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071